Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. Wedevelop gene therapy product candidates designed to provide durableefficacy by inducing sustained expressionof a therapeutic protein. Our core capabilities include clinical development, novel vector discovery, and in-housemanufacturing expertise, specifically in scalable process development, assay development, and current GoodManufacturing Practices (cGMP) quality control. Our team has extensive clinical development experience and islaser-focused on advancing novel gene therapies for patients.
Absorption Systems offers de novo development, optimization, qualification, validation, and GMP-compliant final product and product release testing services for both allogeneic and autologous therapies. We develop both in vitro and in vivo models to better predict human outcomes and correlations between animal studies and in vitro cell-based assays. With over 25 years of expertise, Absorption Systems develops proprietary assays, leveraging our skills in cell and molecular biology, assay development and validation, bioanalytical and immunochemical quantitation, statistical analysis and regulatory affairs within a single-source collaboration. Learn more at www.absorption.com
For 30+ years, Metrovision has been assisting clinicians and researchers with instruments for measuring visual functions. Example, in addition to matching other perimeters feature for feature, the MonCvONE-CR has 18 additional features like computer-assisted Goldmann perimetry, infant perimetry, FST, dark adapted chromatic perimetry, dark adaptometry, pupillometry, binocular synchronized video imaging, ERG and more. Thanks to the modular and easily upgradable design of our instruments, we can propose specific configurations for research applications.